I've been plotting the Phase 2 48-week means from the NEJM paper. Placebo -2.1%, 1mg -8.7%, 4mg -17.1%, 8mg -22.8%, 12mg -24.2%.
What I can't square is the shape: 8mg looks like it flattens around week 36 while 12mg keeps bending down. Is that real dose-response or just attrition and wide CIs? Also curious whether the supplementary appendix has per-visit Ns. I'm not running anything, just trying to read the data properly.